Safety and Immunogenicity of a Rederived, Live-Attenuated Dengue Virus Vaccine in Healthy Adults Living in Thailand: A Randomized Trial
Veerachai Watanaveeradej(Walter Reed Army Institute of Research), Bruce L. Innis(Universidad de Los Andes, Chile), Jean‐François Toussaint(Université Paris Cité), Rafael De La Barrerra(Walter Reed Army Institute of Research), Kenneth H. Eckels(Walter Reed Army Institute of Research), Elodie Tournay(Walter Reed Army Institute of Research), Angkool Kerdpanich(Walter Reed Army Institute of Research), Robert V. Gibbons, Francis Dessy(GlaxoSmithKline (Belgium)), Ananda Nisalak(Armed Forces Research Institute of Medical Science), Sriluck Simasathien(Walter Reed Army Institute of Research), Richard G. Jarman(Walter Reed Army Institute of Research), Stephen J. Thomas(Global Viral)
Cited by 39
Related Papers
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
|New England Journal of Medicine|2020|15.7k
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
|New England Journal of Medicine|2021|937
Rapid development of a DNA vaccine for Zika virus
|Science|2016|402
A Recombinant Vesicular Stomatitis Virus Ebola Vaccine
|New England Journal of Medicine|2015|390
Bluetongue virus detection by two real-time RT-qPCRs targeting two different genomic segments
|Journal of Virological Methods|2006|342